These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15381873)

  • 41. Anomalies in hepatobiliary excretion of technetium-99m-MAG3 preparations.
    Chatterjee M; Majumder A; Iyer P; Muthukrishnan G; Das MK; Ramamoorthy N; Desai CN; Banerjee S
    Nucl Med Biol; 1996 Oct; 23(7):867-72. PubMed ID: 8971853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of selected preparation variables on the radiochemical purity of 99mTc-sestamibi.
    Norenberg JP; Vaidya MP; Hladik WB; Pathak DR; Born JL; Anderson TL; Carroll TR
    J Nucl Med Technol; 2005 Mar; 33(1):34-41. PubMed ID: 15731019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relative 99mTc-MAG3 renal uptake: reproducibility and accuracy.
    Piepsz A; Tondeur M; Ham H
    J Nucl Med; 1999 Jun; 40(6):972-6. PubMed ID: 10452313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
    Fritzberg AR; Kasina S; Eshima D; Johnson DL
    J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study on 99mTc-MAG3 and 99mTc-DMSA renal accumulation using in vitro cellular model.
    Nový Z; Mandíková J; Trejtnar F
    Ceska Slov Farm; 2011 Feb; 60(1):7-10. PubMed ID: 21648170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A simple method for determining split renal function from dynamic (99m)Tc-MAG3 scintigraphic data.
    Wesolowski MJ; Conrad GR; Šámal M; Watson G; Wanasundara SN; Babyn P; Wesolowski CA
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):550-8. PubMed ID: 26537286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid determination of the radiochemical purity of 99mTc-antimony trisulfide colloid prepared by standard and alternative heating methods.
    Smyth DR
    J Nucl Med Technol; 2006 Sep; 34(3):174-8. PubMed ID: 16951287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of HPLC mixed-mode chromatography in determining radiochemical purity of [(14) C] labeled metformin hydrochloride.
    Truong V; Helmy R; Ren S; Schenk D; Waterhouse D
    J Labelled Comp Radiopharm; 2015 Apr; 58(4):177-9. PubMed ID: 25720824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
    Zhang YR; Zhang YX; Cao W; Lan XL
    J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
    Taylor A; Corrigan P; Eshima D; Folks R
    J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
    Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
    Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
    Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
    J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting the hepatobiliary excretion of 99mTc-MAG3: its clinical significance in routine renography.
    Arroyo AJ; Semaan HB; Minkus KD; Patel YP
    J Nucl Med Technol; 2003 Mar; 31(1):18-20. PubMed ID: 12624122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [99mTc-generator eluates: effects on the radiochemical purity of the labelling products].
    Schomäcker K; Gerad H; Gabruk-Szostak B; Schicha H; Malja S
    Nuklearmedizin; 1994 Feb; 33(1):33-9. PubMed ID: 8134284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noninvasive measurement of renal function with 99mTc-MAG3 gamma-camera renography based on the one-compartment model.
    Oriuchi N; Onishi Y; Kitamura H; Inoue T; Tomaru Y; Higuchi T; Inoue T; Endo K
    Clin Nephrol; 1998 Nov; 50(5):289-94. PubMed ID: 9840316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A better method of quality control for 99mTc-tetrofosmin.
    Hammes R; Joas LA; Kirschling TE; Ledford JR; Knox TL; Nybo MR; Sterzinger JJ
    J Nucl Med Technol; 2004 Jun; 32(2):72-8. PubMed ID: 15175403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of the radiochemical purity of (99m) Tc medronate injection by thin layer chromatography on iTLC-SG: effect of medronate concentration on the value measured.
    Cunnane CM; O'Brien LM; Waight LA; Millar AM
    J Labelled Comp Radiopharm; 2013 May; 56(5):301-4. PubMed ID: 24285375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.